Código QR (código de barras bidimensional)

Latanoprostene Bunod 0.024% Early Experience Program (LEEP): A Canadian Initiative for Open-Angle Glaucoma and Ocular Hypertension

Abstract Introduction Here we report the intraocular pressure (IOP) changes following treatment with latanoprostene bunod (LBN) 0.024% in patients in Canadian ophthalmology practices. Methods This real-world, open-label, 6-week, observational study collected data from 59 Canadian ophthalmologists an...

ver descrição completa

Na minha lista:
Principais autores: David Yan, Cindy M. L. Hutnik, Paul Harasymowycz
Formato: Artigo
Idioma:Inglês
Publicado em: Adis, Springer Healthcare 2025-04-01
coleção:Ophthalmology and Therapy
Assuntos:
Intraocular pressure
Latanoprostene bunod
Open-angle glaucoma
Ocular hypertension
Nitric oxide donor
Patient satisfaction
Acesso em linha:https://doi.org/10.1007/s40123-025-01132-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados